{
    "SPADE_UN_27604": {
        "Sequence Information": {
            "Peptide Name": "LL-37(13-37)",
            "Sequence": "IGKEFKRIVQRIKDFLRNLVPRTES",
            "Sequence Length": 25,
            "Biological Activity": [
                "Anti-Gram+",
                "Anti-Gram-",
                "Anticancer",
                "Anti-Mammalian Cell"
            ],
            "Binding Target": "1. Lipid Bilayer",
            "Source": "",
            "Gene": "",
            "PDB ID": "2FCG",
            "UniProt Entry": [
                {
                    "uniprotId": "P49913",
                    "uniprotUrl": "http://www.uniprot.org/uniprot/P49913",
                    "description": "The amino acid sequence of the current peptide coincides with the part of the UniProt entry that represents a peptide precursor."
                }
            ],
            "Literature": [
                {
                    "Title": "Solution structures of human LL-37 fragments and NMR-based identification of a minimal membrane-targeting antimicrobial and anticancer region.",
                    "Pubmed ID": "16637646",
                    "Reference": "J Am Chem Soc. 2006;128:5776-5785",
                    "Author": "Li X, Li Y, Han H, Miller DW, Wang G",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/16637646"
                },
                {
                    "Title": "Evaluation of LL-37 antimicrobial peptide derivatives alone and in combination with vancomycin against S. aureus.",
                    "Pubmed ID": "30120393",
                    "Reference": "J Antibiot (Tokyo). 2018;71:971-974",
                    "Author": "Shurko JF, Galega RS, Li C, Lee GC",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/30120393"
                }
            ],
            "Mass": 3043.57,
            "PI": 10.93,
            "Net Charge": 4,
            "Hydrophobicity": -0.62,
            "Frequent Amino Acids": "RIK",
            "Absent Amino Acids": "ACHMOUWY",
            "Basic Residues": 7,
            "Acidic Residues": 3,
            "Hydrophobic Residues": 9,
            "Polar Residues": 16,
            "Positive Residues": 7,
            "Negative Residues": 3,
            "SPADE ID": "SPADE_UN_27604",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_02277",
                    "Similarity": 1.0,
                    "Sequence": "GDFFRKSKEKIGKEFKRIVQRIKDFLRN"
                },
                {
                    "SPADE_ID": "SPADE_N_03100",
                    "Similarity": 1.0,
                    "Sequence": "KSKEKIGKEFKRIVQRIKDFLRNLVPR"
                },
                {
                    "SPADE_ID": "SPADE_N_03107",
                    "Similarity": 1.0,
                    "Sequence": "ALLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES"
                }
            ],
            "Hemolytic Activity": "Human brain microvascular endothelial cells HBMEC:50% Cell death=38±3 µM",
            "Target Organism": "Escherichia coli K-12(MIC=80µM),Human epithelial carcinoma KBv(LC50=39±0µM),Human epithelial carcinoma KB(LC50=40±0µM),Staphylococcus aureus ATCC 25923(MIC=512µg/ml),Staphylococcus aureus ATCC 43300(MIC=512µg/ml),Staphylococcus aureus ATCC 700699(MIC=1024µg/ml),Staphylococcus aureus(MIC=512µg/ml)"
        }
    }
}